Laughter Therapy Effects on Mood, Stress and Self-efficacy in People With Neurological Diseases.
Completed · Not applicable
Conditions studied: Alzheimer's Disease, Amyotrophic Lateral Sclerosis, Brain Injury, Huntington's Disease, Multiple Sclerosis, Parkinson's Disease, Stroke, Spinal Cord Injury
In brief
This is a prospective investigation of the effects of Laughter therapy (LT) on perceived stress, self-efficacy, mood and other wellness measures in people with the following neurological conditions: Alzheimer's disease, amyotrophic lateral sclerosis, brain injury, Huntington's Disease, multiple sclerosis, Parkinson's Disease, post-stroke, spinal cord injury.
Key facts
- Study ID
- NCT02750982
- Run by
- Brown, Theodore R., M.D., MPH
- People needed
- 24
- Starts
- 2016-07-01
- Expected to finish
- 2018-08-01
- Last updated by the study team
- 2018-09-26
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosis based on medical record review of one of the following neurological diseases: Alzheimer's disease, amyotrophic lateral sclerosis, brain injury, Huntington's Disease, Multiple Sclerosis, Parkinson's Disease, Post-Stroke, Spinal Cord Injury.
- Medically stable for at least 2 months.
- Not participating in Laughter therapy for 30 days prior to screening.
You may not qualify if…
- Females who are pregnant
- Any unstable medical condition
- Severe cognitive deficits that would interfere with participation (e.g. unable to follow commands).
- Severe abdominal pain, chest pain or back pain.
- Abdominal, chest or back surgery within 90 days.
- Psychosis or severe mental illness.
- Untreated hernia.
- Persistent cough.
- Advanced hemorrhoids.
- Epilepsy.
- Uncontrolled Hypertension - SBP >170 or DBP >105.
Where it is running
- Evergreen Healthcare — Kirkland, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.